These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16789995)

  • 1. Is brimonidine ophthalmic a safe therapy for infants?
    Daubert GP
    J Clin Pharm Ther; 2006 Jun; 31(3):289-92. PubMed ID: 16789995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers.
    Mungan NK; Wilson TW; Nischal KK; Koren G; Levin AV
    J AAPOS; 2003 Feb; 7(1):69-70. PubMed ID: 12690374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of brimonidine 0.2% as adjunctive therapy for patients with glaucoma inadequately controlled with otherwise maximal medical therapy.
    thoe Schwartzenberg GW; Buys YM
    Ophthalmology; 1999 Aug; 106(8):1616-20. PubMed ID: 10442912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-effect profile of brimonidine tartrate in children.
    Al-Shahwan S; Al-Torbak AA; Turkmani S; Al-Omran M; Al-Jadaan I; Edward DP
    Ophthalmology; 2005 Dec; 112(12):2143. PubMed ID: 16225927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children.
    Bowman RJ; Cope J; Nischal KK
    Eye (Lond); 2004 Jan; 18(1):24-6. PubMed ID: 14707960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of glaucoma with brimonidine (Alphagan 0.2%)].
    Detry-Morel M; Dutrieux C
    J Fr Ophtalmol; 2000 Oct; 23(8):763-8. PubMed ID: 11033496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alpha-2 adrenergic agonists in the treatment of glaucoma].
    Apătăchioae I; Chiseliţă D
    Oftalmologia; 1999; 47(2):35-40. PubMed ID: 10641099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic side effects of ophthalmic drops.
    Levy Y; Zadok D
    Clin Pediatr (Phila); 2004; 43(1):99-101. PubMed ID: 14968900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of brimonidine in children with glaucoma.
    Enyedi LB; Freedman SF
    J AAPOS; 2001 Oct; 5(5):281-4. PubMed ID: 11641636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent central nervous system depression in infants after the use of topical brimonidine.
    Carlsen JO; Zabriskie NA; Kwon YH; Barbe ME; Scott WE
    Am J Ophthalmol; 1999 Aug; 128(2):255-6. PubMed ID: 10458196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to topical apraclonidine in children with glaucoma.
    Wright TM; Freedman SF
    J Glaucoma; 2009; 18(5):395-8. PubMed ID: 19525731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic toxicity from subcutaneous brimonidine injection successfully treated with naloxone.
    Tobarran N; Kershner E; Chambers A; Cumpston KL; Wills BK
    Am J Emerg Med; 2022 Sep; 59():218.e5-218.e6. PubMed ID: 35835657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brimonidine and pupillary diameter.
    Mastropasqua L; Carpineto P; Ciancaglini M
    Ophthalmology; 1998 Aug; 105(8):1352-3. PubMed ID: 9709738
    [No Abstract]   [Full Text] [Related]  

  • 14. Ophthalmic drops causing coma in an infant.
    Berlin RJ; Lee UT; Samples JR; Rich LF; Tang-Liu DD; Sing KA; Steiner RD
    J Pediatr; 2001 Mar; 138(3):441-3. PubMed ID: 11241061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brimonidine--an alpha 2-agonist for glaucoma.
    Med Lett Drugs Ther; 1997 Jun; 39(1002):54-5. PubMed ID: 9198727
    [No Abstract]   [Full Text] [Related]  

  • 16. Brimonidine hypersensitivity when switching between 0.2% and 0.15% formulations.
    Sullivan-Mee M; Pensyl D; Alldredge B; Halverson K; Gerhardt G; Qualls C
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):355-60. PubMed ID: 20653479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of brimonidine ophthalmic drops ingestion in 52 dogs.
    Welch SL; Richardson JA
    Vet Hum Toxicol; 2002 Feb; 44(1):34-5. PubMed ID: 11824775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brimonidine-induced anterior uveitis and conjunctivitis: clinical and histologic features.
    Nguyen EV; Azar D; Papalkar D; McCluskey P
    J Glaucoma; 2008; 17(1):40-2. PubMed ID: 18303383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic adverse effects of topical treatment with brimonidine in an infant with secondary glaucoma.
    Korsch E; Grote A; Seybold M; Soditt V
    Eur J Pediatr; 1999 Aug; 158(8):685. PubMed ID: 10445353
    [No Abstract]   [Full Text] [Related]  

  • 20. More than just an ocular solution.
    Pekdemir M; Yanturali S; Karakus G
    Emerg Med J; 2005 Oct; 22(10):753-4. PubMed ID: 16189050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.